Case Report

Gestational Trophoblastic Disease with Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ?

Volume: 69 Number: 3 December 31, 2016
Ulaş Kumbasar , Serkan Uysal , Tuba Şahinoğlu , Sevgen Önder , Metin Demircin
PDF Download
Ankara Üniversitesi Tıp Fakültesi Mecmuası Cover Ankara Üniversitesi Tıp Fakültesi Mecmuası
EN TR

Gestational Trophoblastic Disease with Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ?

Abstract

Gestational trophoblastic neoplasms (GTN) originate from placental tissue and usually metastasizes because of its propensity for early vascular invasion. Intracranial metastases are relatively uncommon. There are limited data on the efficacy of 18-fluorodeoxyglucose positron emission tomography (FDG-PET) in the evaluation of metastatic GTN. We present a case of GTN with simultaneous pulmonary and cranial metastases in which the cranial metasteses were undetectable with positron emission tomography (PET) scan.

Keywords

Gestational Trophoblastic Neoplasms, Cranial Metastasis, Positron Emission Tomography

References

  1. 1. Szulman AE. Trophoblastic disease: clinical pathology of hydatidiform moles. Obstet Gynecol Clin North Am 1988;15: 443–456.
  2. 2. Bagshawe KD. Risks and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373–1385.
  3. 3. Berkowitz RS, Goldstein DP. Pathogenesis of gestational trophoblastic neoplasms. Pathobiol Ann 1981;11:391–411.
  4. 4. Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecologic Oncology; 2003;112: 654-662.
  5. 5. Lathrop JC, Lauchlan S, Nayak R. Clinical characteristics of placental site trophoblastic tumor. Gynecol Oncol 1988;31:32-42.
  6. 6. Bagshawe KD, Noble MIM. Cardiorespiratory aspects of trophoblastic tumors. Q J Med 1966;137:39–54.
  7. 7. Suresh TN, Santosh V, Shastry Kolluri VR. Intracranial haemorrhage resulting from unsuspected choriocarcinoma metastasis. Neurol India 2001;49:231–236.
  8. 8. Hammond CB, Weed JC, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Amer J Obstet Gynecol 1980;136:844–856.
  9. 9. Watanabe AS, Smoker WR. Computed tomography and angiographic findings in metastatic choriocarcinoma. J Comput Assist Tomogr 1989;13:319–322.
  10. 10. Dhillon T, Palmieri C, Sebire NJ, et al. Value of whole body 18 FDG-PET to identify the active site of gestational trophoblastic neoplasia. J Reprod Med 2006;51:879–887.

Details

Primary Language

English

Subjects

Surgical Diseases Nursing​​

Journal Section

Case Report

Authors

Publication Date

December 31, 2016

Submission Date

July 7, 2016

Acceptance Date

September 19, 2016

Published in Issue

Year 2016 Volume: 69 Number: 3

IZ

https://izlik.org/JA75FZ33WU

Cite

RIS / Bibtex
APA
Kumbasar, U., Uysal, S., Şahinoğlu, T., Önder, S., & Demircin, M. (2016). Gestational Trophoblastic Disease with Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ? Ankara Üniversitesi Tıp Fakültesi Mecmuası, 69(3), 257-260. https://izlik.org/JA75FZ33WU
AMA
1.Kumbasar U, Uysal S, Şahinoğlu T, Önder S, Demircin M. Gestational Trophoblastic Disease with Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ? Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2016;69(3):257-260. https://izlik.org/JA75FZ33WU
Chicago
Kumbasar, Ulaş, Serkan Uysal, Tuba Şahinoğlu, Sevgen Önder, and Metin Demircin. 2016. “Gestational Trophoblastic Disease With Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ?”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 69 (3): 257-60. https://izlik.org/JA75FZ33WU.
EndNote
Kumbasar U, Uysal S, Şahinoğlu T, Önder S, Demircin M (December 1, 2016) Gestational Trophoblastic Disease with Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ? Ankara Üniversitesi Tıp Fakültesi Mecmuası 69 3 257–260.
IEEE
[1]U. Kumbasar, S. Uysal, T. Şahinoğlu, S. Önder, and M. Demircin, “Gestational Trophoblastic Disease with Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ?”, Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 69, no. 3, pp. 257–260, Dec. 2016, [Online]. Available: https://izlik.org/JA75FZ33WU
ISNAD
Kumbasar, Ulaş - Uysal, Serkan - Şahinoğlu, Tuba - Önder, Sevgen - Demircin, Metin. “Gestational Trophoblastic Disease With Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ?”. Ankara Üniversitesi Tıp Fakültesi Mecmuası 69/3 (December 1, 2016): 257-260. https://izlik.org/JA75FZ33WU.
JAMA
1.Kumbasar U, Uysal S, Şahinoğlu T, Önder S, Demircin M. Gestational Trophoblastic Disease with Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ? Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2016;69:257–260.
MLA
Kumbasar, Ulaş, et al. “Gestational Trophoblastic Disease With Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ?”. Ankara Üniversitesi Tıp Fakültesi Mecmuası, vol. 69, no. 3, Dec. 2016, pp. 257-60, https://izlik.org/JA75FZ33WU.
Vancouver
1.Ulaş Kumbasar, Serkan Uysal, Tuba Şahinoğlu, Sevgen Önder, Metin Demircin. Gestational Trophoblastic Disease with Pulmonary and Cerebral Metastasis: Can Fluorodeoxyglucose Positron Emission Tomography Really Detect Cranial Metastatic Disease ? Ankara Üniversitesi Tıp Fakültesi Mecmuası [Internet]. 2016 Dec. 1;69(3):257-60. Available from: https://izlik.org/JA75FZ33WU